Vivet Therapeutics

Vivet Therapeutics is dedicated to developing innovative gene therapies for orphan diseases. Vivet Therapeutics is committed to optimizing gene therapy through collaboration with the Medica Aplicada Research Foundation (FIMA, University of Navarra), aiming to develop novel AAV vectors specifically targeting the liver and to create new technologies for optimized gene delivery and long-term expression.